BioCentury
ARTICLE | Financial News

Ampio raised $59.5 million

March 1, 2014 1:10 AM UTC

Ampio Pharmaceuticals Inc. (NYSE-M:AMPE) raised $59.5 million through the sale of 8.5 million shares at $7 in a bumped-up follow-on underwritten by Citigroup and Jefferies. Ampio proposed to sell 8 million shares in the offering on Monday, when its share price was $8.98. The company's Ampion is in Phase III testing to treat osteoarthritis (OA) of the knee, with top-line data slated for 3Q14. The product is a cyclic aspartate-alanine dipeptide cleaved from human serum albumin. ...